Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

PTH-CBD agonists may help regrow hair after chemotherapy.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Acitretin effectively improved the woman's skin condition.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.